Research News
A 2020 Pandemic Year in Review: BUSM Steps Up
Original article from BU School of Medicine by Sara Frazier. March 10, 2021 The year 2020 was like no other—it was business as usual for January and most of February, then everything changed in March. On top of the stress and isolation of a global pandemic, 2020 evolved into a year... More
BU Publishes Public Health Data from Its Fall 2020 COVID Surveillance Efforts
Original article from The Brink by Kat J. McAlpine. February 26, 2021 University leadership and scientists, in detailed case study of COVID-related measures and outcomes, hope BU’s insights can aid other institutions, corporations Living, working, and learning amidst a constant viral threat: Boston University leaders and scientists have written a case study... More
Dressed For Success; GMS students join the early fight against COVID-19
Original article from Boston University Medicine by Art Jahnke. Winter 2021 Edition SEE PAGES 14 TO 25 Click Cover or HERE to Read Full Article in Boston University Medicine
A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release
Original article from STAT by Matthew Herper. January 23, 2021 A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will need to be hospitalized.But outside experts said the data... More
How effective is a single vaccine dose against Covid-19?
Original article from BBC by Zaria Gorvett. January 14, 2021 Pretend it didn't happen – expert advice on how to behave after receiving a single dose of any of the Covid-19 vaccines. The cases are already beginning to emerge. When 85-year-old Colin Horseman was admitted to Doncaster Royal Infirmary in late December, it... More
With Two COVID-19 Vaccines on the Way, “We Are in New Territory” (Interview w/ Drs. Corley & Douam)
Original article from The Brink by Kat J. McAlpine. November 17, 2020 A week after Pfizer caused excitement by announcing that its coronavirus vaccine has been more than 90 percent effective in early trials, Moderna came out with its own announcement that its version of a coronavirus vaccine had reached more... More
After Promising Moderna Results, A Public Health Expert Breaks Down The Race For A Vaccine (Interview w/ Dr. Hamer)
Original article from WBUR CommonHealth by Bob Oakes. November 16, 2020 Shares in Cambridge-based Moderna are soaring in premarket trading following positive news about its experimental COVID-19 vaccine. The company reported Monday that thee vaccine was nearly 95% effective in preventing the virus in early U.S. trials. The news comes a week after... More
Tonight’s University Lecture: On the Front Lines against COVID in the Lab, Science Will Win
Original article from BU Today by Joel Brown. November 17, 2020 Joseph Mizgerd hasn’t lost anyone to COVID-19 personally, but that doesn’t mean the pandemic hasn’t affected him. “I’ve had several deaths in the family that were not due to COVID, but they were still deaths that we would like to be... More
What Does Pfizer’s Vaccine News Mean for the Coronavirus Pandemic? (Interview w/ Drs. Connor & Douam)
Original article from The Brink by Kat J. McAlpine. November 10, 2020 As the coronavirus pandemic rages on, with the United States recently reaching a peak of more than 120,000 new cases in a single day, a glimmer of hope appeared on the horizon this week. Pfizer announced that early data... More
In Deadly COVID-19 Lung Inflammation, BU Researchers Discover a Culprit in NFkB Pathway
Original article from The Brink by Kat J. McAlpine. September 24, 2020 As the coronavirus pandemic ripped through through the United States in March, scientists at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) and the Center for Regenerative Medicine (CReM) dropped all other research to focus exclusively on the SARS-CoV-2... More